Collectively, the findings strongly support the participation of NF-κB p65 in the negative regulation of Nrf2-ARE signalling, providing a new insight into a possible role of NF-κB in suppressing the expression of anti-inflammatory or anti-tumour genes [20]. The gene discussed is NFE2L2; the disease is neoplasm.